{"ticker": {"uuid": "9e6f67e3-b284-4613-a941-1909ec1e6ae0", "symbol": "4587", "name": "PeptiDream Inc.", "exchange": "JPX", "country": "JP", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Price to sales forward of Peptidream Inc. \u2013 TSE:4587", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOM3lmVklzT3ZibHlpRE5WZTlRUm5pTFp3TXh0U2hoa0E3cTlPQ3BYZGZ3YTBuNER1bmozX0JhUXo1cjhacXJPUm1UUUxONUw5ZUhrUWJiWWJvYXBjNWFKQ0d0TTVqX0dIaGVqNWRDOGM4Y0p1dHJHbzYxb05mWWktMEpIbm1TcVBVREtDSWwwaFpvNnpQZjJqc0tB?oc=5", "source_name": "TradingView", "published_at": "2026-07-04T23:12:10+00:00", "published_display": "04 Jul 2026 23:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Story Is Shifting For PeptiDream (TSE:4587) After The Price Target Reset", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPWmZWTGZLTzJHWGRCOURLdlczODZncUFwWXRqdzdfTkZyZkVOOEJXUUQyT2M2cmkzV0RnSkE3elpJYlpyQXNNYUJ4UWRfVmJVY2RTbWFyRUFXZG9pMF9zNFpmVHdYZ1RwaGQ3MTZMUzQzOU5pR0lXcDlqYjhPb3dlZEdHVjlWdGRNNkV5MkNIanFWa3B6Z0x5TnVwbk1fR29J?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PeptiDream Announces the Initiation of Phase 1 Clinical Trial by Its Collaboration Partner", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxOc3RhazlaNWRLVGJZNjluVHNISVpqNU5DSUJoWDF0M1VXTkhFZEotd2hQR3pLajFGY3ZCRjJjS1NJQUd1UjJZSDBMbU1SMUJuaGstZWlScG1NcE1pN2Z3MWo1bmtZeFh0TVczUzlUbFdNNExOUkZYVVFBVV8yVV9jc0p3aDI1QVRNVjAzS3ZkVmpCVElIdkV5MEJCNnplOFFlVXpZRnFFbkgxTHRVbWw3RFdEY1pwSXVVV0x0dFI4MHBUTkd0bW43Y0VpU2p2XzlPdVoxQWtCcnYyS3daN1hqRw?oc=5", "source_name": "Business Wire", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Have Lowered Expectations For PeptiDream Inc. (TSE:4587) After Its Latest Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "National Cancer Center Japan and PeptiDream: New Radiopharmaceuticals for Renal Cell Carcinoma", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNelRoVUNYaW1fUVJTYUxNVXBEcW1yQzRjbFVMbzkyNXRmOXVDd3B3dWU4TTVTRlZ3alpOd0hNd1ZWSlNIX2pZREUzVEgxb0g5WHJWOGhPTXRoVlFxTGhIcHdoeFZRS1JNVElHeTFMLVB3NDNHY1Z4anR0YklMWHNWYlZkaXVQc1p1eUZreTRaaXJ3ZHdrNzF0Skc5anE3MFJqalB1aDRXUUxYUlFBU0dmNTNoSVpEcFF5bE04ZElWVzA3WWdUMFZDYWxXSkJpZw?oc=5", "source_name": "BioSpace", "published_at": "2025-03-31T07:00:00+00:00", "published_display": "31 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis, Peptidream expand peptide discovery effort in $2.7B deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQTU1nS3dTVHducXRsd2xwaXBMWGpwT2N1cEhhOVBCcWFFOE4tbm1LdFc4enZmdGFXbVZlM2p3NklCVmxmS1lkY1lxazV0SGFLbnM3YklMWW5JQUw3XzJQblZ1R1FscEZYYmsyNUxxaEVObnVQdFNTYUU1Z3ZLbzBDSUszaWFwbHpwME0wcEo4OFdpdUpiUHhqNkI1ZjN4MklGUXZBSjNUSQ?oc=5", "source_name": "BioWorld News", "published_at": "2024-05-07T07:00:00+00:00", "published_display": "07 May 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PeptiDream Announces Collaboration and License Agreement with MSD for the Discovery and Development of Novel Peptide Drug Conjugates", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAJBVV95cUxPZVBOdUZhUTMweGstd3hCWVN3X2l4Y2VweExDa1R6Y3RBTEJOdE5oUnZZc1c5Uk1scVFnUHhvcXdaSkJXODJTbnloOTR4VWxCUllDcFEzQU1WMzVvbmFZY1dRUlI1QVJQX0ZQcDV3VjhMV0tBTERsRndRalh3amFfV0NUNlEtUGlLOUVzcUNCN0o2RGNIcmM2MVhVOUZXTW9ob1dwRmFhMldSZDlFTjVBQU1uRzMzUkJ1OERQNjhDZ2UxOVI5WFZxVmdERkVZOUZlTWFUOUdFdC03Ukhudl9KSlJ3bjV6Q3lERzBtSW1GeVJWOG5DSEk0Mmdxa0tON09rYnVTenJuemwwVHU3TGR6alRHT1R4eEhx?oc=5", "source_name": "Business Wire", "published_at": "2022-12-27T08:00:00+00:00", "published_display": "27 Dec 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotech-for-hire PeptiDream charts new path and becomes short target", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOVzNzeVZEYzF3NWpmS3hZUGE5M1Rybk5Vb0NSTDRycm11LXNjX0hHVUd0TjItd0w5OEtVZ05URURzX0xtd3E5aThSLUZ3N1pVelVrMldSWGsyQnVYREFlVUZqZTBSXzBEeG80X1RXQWpJOUptWVg5UWlYamdES3c3RzQzQUstMGpOaHdzZ1lsNGRiNHoxcHFLXzZLelpwTGZOaUhKcVJxTTF4RDh2R0FJNHpXWkF2eldhSzhZQm1DeW9OVFdF?oc=5", "source_name": "Reuters", "published_at": "2019-11-13T08:00:00+00:00", "published_display": "13 Nov 2019 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Price to sales forward of Peptidream Inc. \u2013 TSE:4587", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOM3lmVklzT3ZibHlpRE5WZTlRUm5pTFp3TXh0U2hoa0E3cTlPQ3BYZGZ3YTBuNER1bmozX0JhUXo1cjhacXJPUm1UUUxONUw5ZUhrUWJiWWJvYXBjNWFKQ0d0TTVqX0dIaGVqNWRDOGM4Y0p1dHJHbzYxb05mWWktMEpIbm1TcVBVREtDSWwwaFpvNnpQZjJqc0tB?oc=5", "source_name": "TradingView", "published_at": "2026-07-04T23:12:10+00:00", "published_display": "04 Jul 2026 23:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Story Is Shifting For PeptiDream (TSE:4587) After The Price Target Reset", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPWmZWTGZLTzJHWGRCOURLdlczODZncUFwWXRqdzdfTkZyZkVOOEJXUUQyT2M2cmkzV0RnSkE3elpJYlpyQXNNYUJ4UWRfVmJVY2RTbWFyRUFXZG9pMF9zNFpmVHdYZ1RwaGQ3MTZMUzQzOU5pR0lXcDlqYjhPb3dlZEdHVjlWdGRNNkV5MkNIanFWa3B6Z0x5TnVwbk1fR29J?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PeptiDream Announces the Initiation of Phase 1 Clinical Trial by Its Collaboration Partner", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxOc3RhazlaNWRLVGJZNjluVHNISVpqNU5DSUJoWDF0M1VXTkhFZEotd2hQR3pLajFGY3ZCRjJjS1NJQUd1UjJZSDBMbU1SMUJuaGstZWlScG1NcE1pN2Z3MWo1bmtZeFh0TVczUzlUbFdNNExOUkZYVVFBVV8yVV9jc0p3aDI1QVRNVjAzS3ZkVmpCVElIdkV5MEJCNnplOFFlVXpZRnFFbkgxTHRVbWw3RFdEY1pwSXVVV0x0dFI4MHBUTkd0bW43Y0VpU2p2XzlPdVoxQWtCcnYyS3daN1hqRw?oc=5", "source_name": "Business Wire", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Have Lowered Expectations For PeptiDream Inc. (TSE:4587) After Its Latest Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "National Cancer Center Japan and PeptiDream: New Radiopharmaceuticals for Renal Cell Carcinoma", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNelRoVUNYaW1fUVJTYUxNVXBEcW1yQzRjbFVMbzkyNXRmOXVDd3B3dWU4TTVTRlZ3alpOd0hNd1ZWSlNIX2pZREUzVEgxb0g5WHJWOGhPTXRoVlFxTGhIcHdoeFZRS1JNVElHeTFMLVB3NDNHY1Z4anR0YklMWHNWYlZkaXVQc1p1eUZreTRaaXJ3ZHdrNzF0Skc5anE3MFJqalB1aDRXUUxYUlFBU0dmNTNoSVpEcFF5bE04ZElWVzA3WWdUMFZDYWxXSkJpZw?oc=5", "source_name": "BioSpace", "published_at": "2025-03-31T07:00:00+00:00", "published_display": "31 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis, Peptidream expand peptide discovery effort in $2.7B deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQTU1nS3dTVHducXRsd2xwaXBMWGpwT2N1cEhhOVBCcWFFOE4tbm1LdFc4enZmdGFXbVZlM2p3NklCVmxmS1lkY1lxazV0SGFLbnM3YklMWW5JQUw3XzJQblZ1R1FscEZYYmsyNUxxaEVObnVQdFNTYUU1Z3ZLbzBDSUszaWFwbHpwME0wcEo4OFdpdUpiUHhqNkI1ZjN4MklGUXZBSjNUSQ?oc=5", "source_name": "BioWorld News", "published_at": "2024-05-07T07:00:00+00:00", "published_display": "07 May 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PeptiDream Announces Collaboration and License Agreement with MSD for the Discovery and Development of Novel Peptide Drug Conjugates", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAJBVV95cUxPZVBOdUZhUTMweGstd3hCWVN3X2l4Y2VweExDa1R6Y3RBTEJOdE5oUnZZc1c5Uk1scVFnUHhvcXdaSkJXODJTbnloOTR4VWxCUllDcFEzQU1WMzVvbmFZY1dRUlI1QVJQX0ZQcDV3VjhMV0tBTERsRndRalh3amFfV0NUNlEtUGlLOUVzcUNCN0o2RGNIcmM2MVhVOUZXTW9ob1dwRmFhMldSZDlFTjVBQU1uRzMzUkJ1OERQNjhDZ2UxOVI5WFZxVmdERkVZOUZlTWFUOUdFdC03Ukhudl9KSlJ3bjV6Q3lERzBtSW1GeVJWOG5DSEk0Mmdxa0tON09rYnVTenJuemwwVHU3TGR6alRHT1R4eEhx?oc=5", "source_name": "Business Wire", "published_at": "2022-12-27T08:00:00+00:00", "published_display": "27 Dec 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotech-for-hire PeptiDream charts new path and becomes short target", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOVzNzeVZEYzF3NWpmS3hZUGE5M1Rybk5Vb0NSTDRycm11LXNjX0hHVUd0TjItd0w5OEtVZ05URURzX0xtd3E5aThSLUZ3N1pVelVrMldSWGsyQnVYREFlVUZqZTBSXzBEeG80X1RXQWpJOUptWVg5UWlYamdES3c3RzQzQUstMGpOaHdzZ1lsNGRiNHoxcHFLXzZLelpwTGZOaUhKcVJxTTF4RDh2R0FJNHpXWkF2eldhSzhZQm1DeW9OVFdF?oc=5", "source_name": "Reuters", "published_at": "2019-11-13T08:00:00+00:00", "published_display": "13 Nov 2019 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 77, "total_relevant": 8, "sentiment_summary": {"positive": 0, "negative": 1, "neutral": 7, "score": 48, "total": 8, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 71, "events": [{"event": "general", "label": "Market update", "weight": 2.2, "count": 4}, {"event": "analyst", "label": "Analyst action", "weight": 1.45, "count": 2}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 1019.0, "latest_week": "2026-07-10", "one_week_move": -0.9, "four_week_move": 9.3, "twelve_week_move": -13.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.280503, "market_dynamics_buy_signal": false, "relative_strength": -47.330826, "fair_value_gap": -42.9, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 44.2308, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.9% over one week, +9.3% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 47, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Business Wire", "count": 2}, {"label": "TradingView", "count": 1}, {"label": "Market source", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "BioSpace", "count": 1}, {"label": "BioWorld News", "count": 1}, {"label": "Reuters", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 8}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 4}, {"label": "Analyst action", "count": 2}, {"label": "Earnings", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "48/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "71/100 classification confidence."}, {"label": "Company focus", "value": "8", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-0.9% over one week, +9.3% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Price to sales forward of Peptidream Inc. \u2013 TSE:4587"}], "updated_at": "2026-07-17T18:17:44.618155+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}